For how we live.
The Vaccine Integrity Project, formed in 2025 amid disruptions to the CDC's immunisation advisory committee, sets out its process for reviewing 2026–2027 respiratory-season vaccines.
The advisory committee that shaped U.S. immunization policy for decades was replaced, then bypassed. In March a judge stayed the result.
The appeal is moving on an expedited track, with a status report due this month. But CIDRAP's vaccine-policy trackers make a pointed argument: a working committee could exist right now, if HHS chose to seat one.
The committee's founding document now asks for a 'balanced range' of expertise rather than vaccine-specific knowledge, and adds review of non-vaccine alternatives to its mandate.
Judge Brian Murphy found the government likely broke two federal laws when it bypassed ACIP and replaced its members. The ruling reverts the childhood schedule and cancels this week's ACIP meeting.
A federal recommendation is load-bearing for insurance coverage, the Vaccines for Children programme, and school requirements. States have started building alternatives to all three.
ACIP replaced a recommendation in place since 1991 with individual decision-making for babies born to mothers who test negative. The CDC has not yet adopted it.
The committee meets 18-19 September on COVID-19, hepatitis B and MMRV vaccines. RSV was dropped two days before. Adopted recommendations carry insurance and Vaccines for Children consequences.
A Federal Register notice on 9 June listed eleven vaccine topics and ten scheduled votes over three days. An amended notice on 24 June listed seven topics, three votes and two days.